|
Re: First xB3 platform technology licensing agreement with Prothena; USD$1M upfront+potential up to USD$33M in payments
|
3
|
BIOASIS TECHNOLOGIES INC
|
Oct 29, 2018 08:40AM
|
|
Re: MACE event rate
|
3
|
Resverlogix Corp.
|
Nov 05, 2018 11:43AM
|
|
Re: Why I think it's a homerun
|
3
|
Resverlogix Corp.
|
Mar 03, 2019 05:10PM
|
|
Re: Apabetalone for non diabetics or normal cholesterol?
|
3
|
Resverlogix Corp.
|
Dec 10, 2019 08:32AM
|
|
Re: Interesting Uptick
|
3
|
Resverlogix Corp.
|
Apr 28, 2016 12:36PM
|
|
Re: Breakthrough Therapy Designation Application
|
3
|
Resverlogix Corp.
|
Dec 06, 2019 10:07AM
|
|
Zacks SCR Report 4/12/2018
|
3
|
Resverlogix Corp.
|
Apr 13, 2018 01:40PM
|
|
Re: Resverlogix H2 2018 events
|
3
|
Resverlogix Corp.
|
Nov 05, 2018 11:49AM
|
|
Re: Biotech Showcase Presentation is up
|
3
|
Resverlogix Corp.
|
Jan 07, 2019 10:17PM
|
|
Re: Crispr-cas9 Patent Dispute -- Off-topic? Or do we have a similar situation?
|
3
|
Resverlogix Corp.
|
Nov 01, 2016 04:07PM
|
|
Zenith Epigenetics Announces Publication in Journal of Cancer Gene Therapy with Compelling Data for Treatment of ER-Positive Breast Cancer Patients
|
3
|
Zenith Epigenetics
|
Aug 17, 2021 09:42PM
|
|
Do we have a pipeline and is it promising?
|
3
|
Resverlogix Corp.
|
Apr 05, 2017 11:28AM
|
|
Re: No answer yet on what the change in study protocol is....
|
3
|
Resverlogix Corp.
|
Jul 28, 2017 01:24PM
|
|
Re: Radio Silence
|
3
|
Resverlogix Corp.
|
Jun 03, 2019 03:59PM
|
|
Re: New Zach's Report: $3 Price Target
|
3
|
Resverlogix Corp.
|
Aug 14, 2015 04:47PM
|
|
Re: March Madness?
|
3
|
Resverlogix Corp.
|
Mar 12, 2018 12:16PM
|
|
Re: RVX files notice of meeting...
|
3
|
Resverlogix Corp.
|
May 18, 2015 11:07AM
|
|
Re: ACC 2019 Abstracts
|
3
|
Resverlogix Corp.
|
Mar 16, 2019 08:06PM
|
|
Re: Note from Sarah Re: Orphan etc.....
|
3
|
Resverlogix Corp.
|
Jul 01, 2015 11:04AM
|
|
Re: March Madness
|
3
|
Resverlogix Corp.
|
Mar 14, 2017 04:09PM
|
